Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
43 studies found for:    Open Studies | "Bacteremia"
Show Display Options
Rank Status Study
1 Recruiting A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
Condition: Bacteremia
Interventions: Drug: Telavancin;   Drug: Vancomycin;   Drug: Daptomycin;   Drug: Synthetic penicillin;   Drug: Cefazolin
2 Recruiting Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT
Condition: Bacteremia
Interventions: Other: 7 days of adequate antibiotic treatment durations;   Other: 14 days of adequate antibiotic treatment durations
3 Recruiting Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia
Condition: Gram Negative Bacteremia
Interventions: Drug: short-course antibiotic treatment;   Drug: accepted prolonged antibiotic treatment
4 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin 10mg/kg/24h iv
5 Recruiting The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia
Condition: Staphylococcus Aureus Bacteremia
Intervention: Procedure: FDG PET CT
6 Recruiting A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus
Condition: Staphylococcus Aureus Bacteremia
Interventions: Biological: 514G3;   Drug: Placebo;   Drug: Standard IV antibiotic therapy
7 Not yet recruiting BALANCE on the Wards: A Pilot RCT
Condition: Bacteremia
Interventions: Other: 7 days of adequate antibiotic treatment;   Other: 14 days of adequate antibiotic treatment
8 Recruiting Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
Conditions: Methicillin Susceptible Staphylococcus Aureus Septicemia;   Bacteremia
Interventions: Drug: Daptomycin;   Other: Placebo
9 Not yet recruiting An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures
Conditions: Bacteraemia;   Endocarditis
Interventions: Drug: Amoxicillin;   Drug: Amoxicillin-Potassium Clavulanate
10 Recruiting IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
Condition: Bacteremia
Interventions: Drug: Daptomycin;   Drug: Vancomycin;   Drug: Ceftaroline
11 Recruiting Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study
Conditions: Cancer;   Bacteremia
Intervention:
12 Recruiting Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Conditions: Cholangitis;   Bacteremia
Intervention: Procedure: Cholangioscopy
13 Recruiting Safety Evaluation of Seraph® to Reduce Bacteremia in Patients on Hemodialysis
Conditions: Bacteremia;   Bacterial Infection
Intervention: Device: Seraph Microbind Affinity Blood Filter
14 Recruiting Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.
Conditions: Bacteremia;   Infant, Very Low Birth Weight
Interventions: Device: Edelvaiss Multiline NEO;   Device: Standard Infusion Set
15 Recruiting T2Bacteria Panel Pivotal Study
Condition: Bacteremia
Intervention:
16 Recruiting Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
Condition: Bacteremia
Intervention: Drug: Vancomycin
17 Recruiting Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Condition: Gram-Negative Bacterial Infections
Intervention:
18 Recruiting Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters.
Condition: Catheter Related Infections
Interventions: Device: CVC;   Device: PICC
19 Recruiting Prevention of Nosocomial Bacteremia Among Zambian Neonates
Conditions: Neonatal Sepsis;   Neonatal Mortality
Interventions: Drug: Chlorhexidine gluconate (CHG);   Behavioral: Hand hygiene (HH);   Behavioral: Infection control training;   Other: Infection control reminders via SMS text
20 Recruiting The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421
Condition: Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.